Table 1. Peptides Used in the Study and Associated Characteristics.
name/series | increment | sequence | length | molecular weight | net charge | hydrophobicity | hydrophobic moment |
---|---|---|---|---|---|---|---|
P1 | RKLKKLWRKFR | 11 | 1558.983 | 6.997 | –1.782 | 0.969 | |
P2 | RRFVKKVRKLVK | 12 | 1557.008 | 6.997 | –0.825 | 0.976 | |
P3 | FRWLRKWFRR | 10 | 1550.878 | 4.998 | –1.430 | 1.045 | |
SP1 | KKRRFRWLKLK | 11 | 1558.983 | 6.997 | –1.782 | 0.161 | |
SP2 | RKLRKKVFVKRV | 12 | 1557.008 | 6.997 | –0.825 | 0.253 | |
SP3 | WKRLRWRRFF | 10 | 1550.878 | 4.998 | –1.430 | 0.173 | |
series 1 | 0.00 | VIREHKYVLLL | 11 | 1382.712 | 1.090 | 0.718 | 0.366 |
series 1 | 0.33 | LPKIKKTVSTR | 11 | 1270.582 | 3.997 | –0.682 | 0.345 |
series 1 | 0.66 | LLKSGRLLMKI | 11 | 1271.671 | 2.997 | 0.736 | 0.637 |
series 1 | 0.99 | KKIKRFLRKIG | 11 | 1386.793 | 5.997 | –0.855 | 1.015 |
series 2 | 0.00 | GLGIIPHRRYGK | 12 | 1366.632 | 3.088 | –0.617 | 0.325 |
series 2 | 0.33 | GIMSLFKGVLKT | 12 | 1293.631 | 1.997 | 0.908 | 0.589 |
series 2 | 0.66 | GLFKIIKNIFSG | 12 | 1336.640 | 1.997 | 0.833 | 0.676 |
series 2 | 0.99 | KLFRIIKRIFKG | 12 | 1518.955 | 4.997 | 0.150 | 1.075 |